Technology
Health
Medical

Neurotrope

$7.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-0.99%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Neurotrope and other stocks, options, ETFs, and crypto commission-free!

About

Neurotrope, Inc. Common Stock, also called Neurotrope, is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. Read More The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY.

Employees
6
Headquarters
New York, New York
Founded
2011
Market Cap
90.84M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
46.22K
High Today
$7.22
Low Today
$7.01
Open Price
$7.12
Volume
21.52K
52 Week High
$11.93
52 Week Low
$3.33

Collections

Technology
Health
Medical
Biopharmaceutical
Pharmaceutical
2013 IPO
US
North America
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.